What is YMT's health score?

Yimutian Inc. (YMT) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is YMT's estimated fair value?

Based on our 5-year discounted cash flow model, Yimutian Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is YMT undervalued or overvalued?

Our model currently rates YMT as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for YMT... Refresh in a moment for the full analysis.

Yimutian Inc. (YMT)

Technology Inconclusive inconclusive weak

$0.84

Updated: 2026-06-06

TradeApes Score

Financial Strength

20 Stressed

Operating Trend

58 Mixed

Relative Value

50 Mixed

Capital Allocation

30 Weak

Risk

35 Weak

Key Findings

+ Low leverage — net debt/EBITDA below 1×

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.